TipRanks
TipRanksTop Financial ExpertsInsidersRekha Hemrajani

Rekha Hemrajani Insider Profile

4 Followers
Rekha Hemrajani, Director at MaxCyte, holds 70.31K shares in MaxCyte (Ticker: MXCT), holds ― shares in Arcus Biosciences (Ticker: RCUS), holds ― shares in Adverum Biotechnologies (Ticker: ADVM).
See the Hottest Stocks Based on Insider Trading >
tipranks
Rekha Hemrajani

Rekha Hemrajani
MaxCyte (MXCT)
Director

Ranked #37,540 out of 109,193 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+38.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$125K
63.19%
36.81%
0.00%
0.00%
0.00% Others
A breakdown of Rekha Hemrajani's holdings
See the Top Stocks by Insiders

Insider Roles

MaxCyte
(MXCT)
Director
ALX Oncology Holdings
(ALXO)
Director
Arcus Biosciences
(RCUS)
See Remarks
BioAge Labs, Inc.
(BIOA)
Director
+1 other positions
Roles that Rekha Hemrajani holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
ALX Oncology Holdings
(ALXO)
Rating:Informative Buy
Date:Jul 21, 2020 - Jul 21, 2021
Return:+89.70%
The most profitable trade made by Rekha Hemrajani
See the Latest Stocks Traded by Insiders

Rekha Hemrajani's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MXCT
MaxCyte
Jun 22, 2026
Director
Uninformative Buy
―
$78.75K
RCUS
Arcus Biosciences
―
See Remarks
―
―
ADVM
Adverum Biotechnologies
―
―
―
―
ARAV
Aravive
Apr 09, 2020
―
Uninformative Sell
―
$570.00
ALXO
ALX Oncology Holdings
Dec 04, 2024
Director
Informative Buy
46.20K
$45.87K
BIOA
BioAge Labs, Inc.
―
Director
―
―
LBRX
LB Pharmaceuticals, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Rekha Hemrajani's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Rekha Hemrajani insider profile FAQ

What is the percentage of profitable transactions made by Rekha Hemrajani?
The percentage of profitable transactions made by Rekha Hemrajani is 50%.
    What is the average return per transaction made by Rekha Hemrajani?
    The average return per transaction made by Rekha Hemrajani is 38.80%.
      What stocks does Rekha Hemrajani hold?
      Rekha Hemrajani holds: MXCT, RCUS, ADVM, ARAV, ALXO, BIOA, LBRX stocks.
        What was Rekha Hemrajani’s latest transaction?
        Rekha Hemrajani latest transaction was an Uninformative Buy of ―.
          What was Rekha Hemrajani's most profitable transaction?
          Rekha Hemrajani’s most profitable transaction was an Informative Buy of ALXO stock on July 21, 2020. The return on the trade was 89.70%.
            What is Rekha Hemrajani's role in MaxCyte?
            Rekha Hemrajani's role in MaxCyte is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.